CD4 and neoplasm: FTY720 treatment beginning 2 days but not 8 days post tumor inoculation prevented immunotherapeutic vaccination from significantly reducing tumor burden (Figure 3e) even though any group that received FTY720 had significantly fewer CD4+ T cells within the tumor compared to animals that did not (Figure 3f).